How Trump Is Hustling Consumers To Protect Pharma Profits

How Trump Is Hustling Consumers To Protect Pharma Profits

Pegging drug prices to rates paid abroad, a great idea as proposed during the first Trump administration, is getting a second life — this time as a tool for preserving Big Pharma’s earnings power.The president on Thursday sent letters to the CEOs of every major drug company demanding they sell their products in the U.S. at what he called “most favored nation” (MFN) prices. The original rule, proposed in late 2020, set those prices at the average…

The $400 Billion Patent Cliff: Big Pharma’s Revenue Crisis

By Ajay Raju   President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies demanding they lower U.S. drug prices to match international levels, with a September 29 deadline. The companies—including Pfizer, Merck, J&J, and others already facing a pending patent cliff—must provide their full drug portfolios to Medicaid patients at prices aligned with other wealthy countries and guarante…